These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reply to letters regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation". Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG Circulation; 2014 Jun; 129(24):e656. PubMed ID: 24934470 [No Abstract] [Full Text] [Related]
4. Letter by Scharnagl et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation". Scharnagl H; Kleber ME; März W Circulation; 2014 Jun; 129(24):e654. PubMed ID: 24934468 [No Abstract] [Full Text] [Related]
5. Letter by Jones et al regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation". Jones SR; Martin SS; Brinton EA Circulation; 2014 Jun; 129(24):e655. PubMed ID: 24934469 [No Abstract] [Full Text] [Related]
7. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Varbo A; Benn M; Nordestgaard BG Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311 [TBL] [Abstract][Full Text] [Related]
8. Combined Effect of Small Dense Low-Density Lipoprotein Cholesterol (sdLDL-C) and Remnant-Like Particle Cholesterol (RLP-C) on Low-Grade Inflammation. Izumida T; Nakamura Y; Hino Y; Ishikawa S J Atheroscler Thromb; 2020 Apr; 27(4):319-330. PubMed ID: 31462603 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862 [TBL] [Abstract][Full Text] [Related]
10. Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia. Stein DT; Devaraj S; Balis D; Adams-Huet B; Jialal I Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2026-31. PubMed ID: 11742880 [TBL] [Abstract][Full Text] [Related]
11. Effects of statin on small dense low-density lipoprotein cholesterol and remnant-like particle cholesterol in heterozygous familial hypercholesterolemia. Nozue T; Michishita I; Ito Y; Hirano T J Atheroscler Thromb; 2008 Jun; 15(3):146-53. PubMed ID: 18603821 [TBL] [Abstract][Full Text] [Related]
13. [Overview: Atherogenic lipoproteins and their clinical significance]. Shirai K Nihon Rinsho; 2004 Dec; 62 Suppl 12():5-9. PubMed ID: 15658249 [No Abstract] [Full Text] [Related]
14. [Dyslipoproteinemia as a coronary risk factor]. Yamamura T Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059 [No Abstract] [Full Text] [Related]
15. Effect of dietary carbohydrate restriction with and without weight loss on atherogenic dyslipidemia. Wood RJ Nutr Rev; 2006 Dec; 64(12):539-45. PubMed ID: 17274496 [TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism: lipoproteins in the metabolic syndrome and subclass sex and age differences. van Heyningen C Curr Opin Lipidol; 2005 Feb; 16(1):119-20. PubMed ID: 15650571 [No Abstract] [Full Text] [Related]
17. Remnant cholesterol as a causal risk factor for ischemic heart disease. Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341 [TBL] [Abstract][Full Text] [Related]
18. Male and female cord blood lipoprotein profile differences throughout the term-period. Bastida S; Sánchez-Muniz FJ; Cuesta C; Perea S; Aragonés A J Perinat Med; 1997; 25(2):184-91. PubMed ID: 9189839 [TBL] [Abstract][Full Text] [Related]
19. High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia. Twickler TB; Dallinga-Thie GM; de Valk HW; Schreuder PC; Jansen H; Cabezas MC; Erkelens DW Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2422-7. PubMed ID: 11073847 [TBL] [Abstract][Full Text] [Related]
20. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. Lamarche B; Tchernof A; Mauriège P; Cantin B; Dagenais GR; Lupien PJ; Després JP JAMA; 1998 Jun; 279(24):1955-61. PubMed ID: 9643858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]